Board of Strides Pharma Science to consider fund raising through securities issuance

The Bengaluru-based company did not share details of the amount proposed to be raised.

Published On 2022-07-21 07:45 GMT   |   Update On 2022-07-21 07:45 GMT

New Delhi: Strides Pharma Science has said that its board will meet next week to consider raising funds through issuance of securities.The meeting of the committee of directors is scheduled to be held on July 25, to consider and approve the raising of funds by way of issuance of non-convertible debentures on a private placement basis, the company stated in a BSE filing.The Bengaluru-based...

Login or Register to read the full article

New Delhi: Strides Pharma Science has said that its board will meet next week to consider raising funds through issuance of securities.

The meeting of the committee of directors is scheduled to be held on July 25, to consider and approve the raising of funds by way of issuance of non-convertible debentures on a private placement basis, the company stated in a BSE filing.

The Bengaluru-based company did not share details of the amount proposed to be raised.

Read also: Strides, Akston Biosciences Thermostable 2nd Gen COVID Vaccine trial shows encouraging top-line results

Strides is a global pharmaceutical company headquartered in Bengaluru, India. The Company mainly operates in the regulated markets and has an "in Africa for Africa" strategy along with an institutional business to service donor-funded markets.
The Company's global manufacturing sites are located in India (Chennai, Puducherry and two locations in Bengaluru), Singapore, Italy (Milan), Kenya (Nairobi) and the United States (Florida).
Tags:    
Article Source : with inputs

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News